Ullern A, Garborg KK, Chauhan SK, Holm K, Bang C, Dunn C, Johnsen PH, Hov JER, Kyte JA(2026) Safety and efficacy of fecal microbiota transplantation in solid cancers resistant to immune checkpoint inhibitors: results of the MITRIC trial J Immunother Cancer, 14(7) DOI 10.1136/jitc-2026-015122, PubMed 42476727
Ailte I, Chauhan SK, Prasmickaite L, Bassarova AV, Poissonnier A, Feenstra M, Nyakas M, Johannessen B, Ryder T, Hermann R, Frich L, Holth A, Inderberg EM, Jespersen H, Flørenes VA, Kyte JA, Mælandsmo GM, Egeland EV(2026) CD38hiCD19dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade Front Oncol, 16, 1815008 DOI 10.3389/fonc.2026.1815008, PubMed 42158424
Eide HA, Grut H, Jebsen P, Kyte JA, Bratland Å(2026) Hyperfractionated reirradiation and PD-1 blockade in recurrent squamous cell head and neck carcinomas with poor prognosis, results from the REPORT-trial Radiother Oncol, 219, 111514 DOI 10.1016/j.radonc.2026.111514, PubMed 41916446
